Anticoagulant Prophylaxis for Hospitalized Medical Patients

  1. Mark A. Crowther, MD, MSc;
  2. Francesco Dentali, MD;
  3. Wendy Lim, MD; and
  4. James D. Douketis, MD
  1. From McMaster University, Hamilton, Ontario L8N 3Z5, Canada.

    IN RESPONSE:

    Dr. Lederle and associates question our conclusion that symptomatic VTE in medical patients is reduced during treatment with prophylactic anticoagulants. We acknowledge that a discussion of these matters is important, because our findings could influence the care of many patients.

    First, they indicate that Cohen and colleagues (1) did not confirm all fatal PEs with autopsy. They propose that this would overestimate the risk for such events. We included these events because, in accordance with our prespecified criteria, they were …

    Summary for Patients

    « Previous | Next Article »Table of Contents